MAZE
Maze Therapeutics, Inc.
26.20$
-6.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 3.77 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.00 | 0.34 | |
| 0.02 | 0.02 | 0.02 | – | 0.02 | 0.02 | 0.02 | 0.01 | – | 0.01 | 0.01 | – | – | |
| -0.02 | -0.02 | -0.02 | 3.77 | 0.06 | -0.02 | -0.02 | -0.01 | – | -0.01 | 0.36 | – | – | |
| 0.44 | 0.37 | 0.50 | 0.45 | 0.45 | 0.51 | 0.63 | 0.64 | 0.55 | 0.64 | 0.63 | 0.59 | 2.06 | |
| 0.13 | 0.16 | 0.14 | 0.13 | 0.16 | 0.17 | 0.18 | 0.19 | 0.17 | 0.24 | 0.23 | 0.22 | 0.74 | |
| 0.58 | 0.53 | 0.64 | 0.58 | 0.61 | 0.68 | 0.81 | 0.82 | 0.72 | 0.87 | 0.86 | 0.81 | 2.79 | |
| -0.58 | -0.53 | -0.64 | 3.19 | -0.55 | -0.68 | -0.81 | -0.83 | -0.72 | -0.89 | -0.49 | -0.81 | -2.47 | |
| – | – | – | – | – | – | 0.00 | 0.00 | – | – | 0.02 | 0.02 | – | |
| -0.57 | -0.61 | -0.74 | 3.22 | -0.57 | -0.68 | -0.75 | -0.77 | -0.66 | -0.80 | -0.45 | -0.76 | -2.26 | |
| – | – | – | 0.04 | -0.01 | -0.01 | – | – | – | – | – | – | – | |
| -0.57 | -0.61 | -0.74 | 3.18 | -0.57 | -0.68 | -0.75 | -0.77 | -0.66 | -0.80 | -0.45 | -0.76 | -2.26 | |
| -0.54 | -0.58 | -0.72 | 3.23 | -0.55 | -0.67 | -0.73 | -0.75 | -0.64 | -0.79 | -0.42 | -0.74 | -2.21 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.